Conditions & Recovery · Better Off (Harvard T.H. Chan School of Public Health) · February 24, 2021

We're better off with mRNA vaccines

The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how the mRNA platform could transform the prevention and treatment of deadly diseases.

Originally published by Better Off (Harvard T.H. Chan School of Public Health). We curate and add context; they did the reporting.

Read the full story at Better Off (Harvard T.H. Chan School of Public Health) ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor